000169664 001__ 169664
000169664 005__ 20240229133652.0
000169664 0247_ $$2doi$$a10.1002/cncr.33684
000169664 0247_ $$2pmid$$apmid:34196976
000169664 0247_ $$2ISSN$$a0008-543X
000169664 0247_ $$2ISSN$$a1097-0142
000169664 0247_ $$2ISSN$$a1934-662X
000169664 0247_ $$2ISSN$$a1934-6638
000169664 0247_ $$2altmetric$$aaltmetric:108621146
000169664 037__ $$aDKFZ-2021-01486
000169664 041__ $$aEnglish
000169664 082__ $$a610
000169664 1001_ $$0P:(DE-He78)820d29ab03f702f61c6c92df377d2846$$aLiu, Zhunzhun$$b0$$eFirst author$$udkfz
000169664 245__ $$aDistress mediates the relationship between cognitive appraisal of medical care and benefit finding/posttraumatic growth in long-term cancer survivors.
000169664 260__ $$aHoboken, NJ$$bWiley$$c2021
000169664 3367_ $$2DRIVER$$aarticle
000169664 3367_ $$2DataCite$$aOutput Types/Journal article
000169664 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1642086075_472
000169664 3367_ $$2BibTeX$$aARTICLE
000169664 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000169664 3367_ $$00$$2EndNote$$aJournal Article
000169664 500__ $$a#EA:C071#LA:C071# / 2021 Oct 1;127(19):3680-3690
000169664 520__ $$aThe objective of this study was to ascertain long-term cancer survivors' (LTCS') appraisal of medical care and how these perceptions may influence their health and well-being, including benefit finding (BF) and posttraumatic growth (PTG).In total, 6952 LTCS from a multiregional population-based study in Germany completed the Benefit Finding Scale, the Posttraumatic Growth Inventory, the Questionnaire on Stress in Cancer, and self-designed questions on cognitive appraisal of medical care. The authors explored the mediating role of distress between medical care appraisal and BF and PTG and the possible moderation of time since diagnosis in this relationship.LTCS' medical care appraisals ('no unresolved/untreated symptoms,' 'satisfaction with cancer care,' and 'satisfaction with care for other diseases') were positively associated with BF. PTG was positively associated with 'no unresolved/untreated symptoms' and negatively associated with 'satisfaction with care for other diseases.' Cancer distress partially mediated the associations between appraisals of medical care and BF, between 'no unresolved/untreated symptoms' and PTG and between 'satisfaction with care for other diseases' and PTG; whereas it totally mediated the association between 'satisfaction with cancer care' and PTG. Time was a significant moderator in the model; the negative indirect effect of cognitive appraisal on BF and PTG through cancer distress weakened with longer time since diagnosis.Cancer survivors' medical care appraisal is associated with their perceptions of BF and PTG through distress. Therefore, distress screening could be part of the regular workup to identify distressed cancer survivors who are not satisfied with medical care; these survivors may benefit from interventions to reduce distress and increase BF and PTG.
000169664 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000169664 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
000169664 650_7 $$2Other$$abenefit finding
000169664 650_7 $$2Other$$acancer survivors
000169664 650_7 $$2Other$$acognitive appraisal
000169664 650_7 $$2Other$$adistress
000169664 650_7 $$2Other$$amedical care
000169664 650_7 $$2Other$$amoderator-mediator
000169664 650_7 $$2Other$$aposttraumatic growth
000169664 7001_ $$0P:(DE-He78)55389e9f54d8411e6e6eddcec489bb1b$$aDoege, Daniela$$b1$$udkfz
000169664 7001_ $$0P:(DE-He78)24fe6057396bec79d2638615b12eb989$$aThong, Melissa$$b2$$udkfz
000169664 7001_ $$0P:(DE-He78)13aa5fe9d9961c9fd67193befb0dcf88$$aKoch-Gallenkamp, Lena$$b3$$udkfz
000169664 7001_ $$aBertram, Heike$$b4
000169664 7001_ $$00000-0003-4195-5236$$aEberle, Andrea$$b5
000169664 7001_ $$aHolleczek, Bernd$$b6
000169664 7001_ $$00000-0002-7115-5160$$aNennecke, Alice$$b7
000169664 7001_ $$00000-0002-5909-9936$$aWaldmann, Annika$$b8
000169664 7001_ $$00000-0002-0743-6128$$aZeißig, Sylke Ruth$$b9
000169664 7001_ $$00000-0002-2858-2941$$aPritzkuleit, Ron$$b10
000169664 7001_ $$0P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0$$aArndt, Volker$$b11$$eLast author$$udkfz
000169664 773__ $$0PERI:(DE-600)2599218-1$$a10.1002/cncr.33684$$gp. cncr.33684$$n19$$p3680-3690$$tCancer cytopathology$$v127$$x0008-543X$$y2021
000169664 909CO $$ooai:inrepo02.dkfz.de:169664$$pVDB
000169664 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)820d29ab03f702f61c6c92df377d2846$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000169664 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)55389e9f54d8411e6e6eddcec489bb1b$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000169664 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)24fe6057396bec79d2638615b12eb989$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000169664 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)13aa5fe9d9961c9fd67193befb0dcf88$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000169664 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000169664 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000169664 9130_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000169664 9141_ $$y2021
000169664 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2021-01-28$$wger
000169664 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCER-AM CANCER SOC : 2019$$d2021-01-28
000169664 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-01-28
000169664 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-01-28
000169664 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2021-01-28
000169664 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2021-01-28
000169664 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-01-28
000169664 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2021-01-28
000169664 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-28
000169664 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2021-01-28
000169664 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2021-01-28
000169664 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-28
000169664 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-28
000169664 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-01-28
000169664 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCANCER-AM CANCER SOC : 2019$$d2021-01-28
000169664 9201_ $$0I:(DE-He78)C071-20160331$$kC071$$lC071 Cancer Survivorship$$x0
000169664 980__ $$ajournal
000169664 980__ $$aVDB
000169664 980__ $$aI:(DE-He78)C071-20160331
000169664 980__ $$aUNRESTRICTED